ArticleClinical and translational medicine2024

Targeting CBP revers chemoresistance to 5-FU of CDX2/REG4 double-positive gastric cancer.

Zhiyuan Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.